2.60
price up icon4.42%   0.11
after-market Dopo l'orario di chiusura: 2.66 0.06 +2.31%
loading
Precedente Chiudi:
$2.49
Aprire:
$2.45
Volume 24 ore:
546.82K
Relative Volume:
0.42
Capitalizzazione di mercato:
$24.15M
Reddito:
-
Utile/perdita netta:
$-45.57M
Rapporto P/E:
-0.4127
EPS:
-6.3
Flusso di cassa netto:
$-38.56M
1 W Prestazione:
-8.45%
1M Prestazione:
+44.44%
6M Prestazione:
-36.59%
1 anno Prestazione:
-10.65%
Intervallo 1D:
Value
$2.43
$2.85
Intervallo di 1 settimana:
Value
$2.245
$6.60
Portata 52W:
Value
$1.00
$6.60

Sab Biotherapeutics Inc Stock (SABS) Company Profile

Name
Nome
Sab Biotherapeutics Inc
Name
Telefono
305-845-2813
Name
Indirizzo
777 W 41ST ST, MIAMI BEACH
Name
Dipendente
63
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
SABS's Discussions on Twitter

Confronta SABS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SABS
Sab Biotherapeutics Inc
2.60 23.13M 0 -45.57M -38.56M -6.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-14 Ripresa H.C. Wainwright Buy
2024-10-09 Iniziato Craig Hallum Buy
2024-08-28 Iniziato Oppenheimer Outperform
2021-11-05 Iniziato Chardan Capital Markets Buy

Sab Biotherapeutics Inc Borsa (SABS) Ultime notizie

pulisher
Jul 24, 2025

How SAB Biotherapeutics Inc. Equity Warrant stock reacts to Fed policy changesMarket-beating performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

How SAB Biotherapeutics Inc. stock reacts to Fed policy changesExceptional market positioning - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

SAB Biotherapeutics Shares Jump 33% After Securing $175M in Oversubscribed Private Placement - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about SAB Biotherapeutics Inc. stockFree Expert Stock Watchlist - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is SAB Biotherapeutics Inc. a good long term investmentHigh-performance investment picks - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is SAB Biotherapeutics Inc. Equity Warrant a good long term investmentFree Wealth Planning Blueprint - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

SAB Biotherapeutics Inc. Stock Analysis and ForecastExplosive returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

SAB Biotherapeutics Plunges 10.34% on Private Placement Concerns - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

What drives SAB Biotherapeutics Inc. stock priceMarket-beating performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives SAB Biotherapeutics Inc. Equity Warrant stock priceBreakthrough profit margins - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about SAB Biotherapeutics Inc. Equity Warrant stockExceptional financial outcomes - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

SAB Biotherapeutics Inc. Equity Warrant Stock Analysis and ForecastExplosive trading growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

SAB Biotherapeutics stock price target lowered to $9 by H.C. Wainwright - Investing.com Canada

Jul 22, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics Stock Surges 5.06% to Rank 277th in Trading Volume - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics stock price target raised to $14 from $12 at Oppenheimer - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics Inc (SABS) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

SABS Soars 24.5% on Volatile Intraday Surge—What’s Fueling the Biotech Rally? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics (SABS) up more than 100% since Jun 30 - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SABS Surges 42%—Volatile Rally Reaches 52-Week High Amid Market Turbulence - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Sab Biotherapeutics shares rise 144.48% intraday after raising $175 million in private placement. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics Stock Surge: Should You Buy?​ - StocksToTrade

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics stock soars after securing $175 million private placement By Investing.com - Investing.com Nigeria

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics stock soars after securing $175 million private placement - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

SAB BIO Stock Explodes 54% on Game-Changing $175 Million Private Placement Deal - RagingBull

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics Secures $175M in Private Placement - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics announces oversubscribed $175M private placement - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

SAB BIO Announces Oversubscribed $175 Million Private Placement - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

SAB BIO Secures $175M Funding Led by Sanofi to Advance Revolutionary Type 1 Diabetes Treatment Through 2028 - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

SABS Stock on the Rise: What’s Next? - timothysykes.com

Jul 21, 2025
pulisher
Jul 20, 2025

Published on: 2025-07-20 20:52:24 - jammulinksnews.com

Jul 20, 2025

Sab Biotherapeutics Inc Azioni (SABS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):